Guillaume Vaiva, MD, PhD

  • 12Articles
  • 77.5KReads
  • 2011–2025Active
  • 96Collaborators
  • 456Citations

About

Guillaume Vaiva, MD, PhD is affiliated with University Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience and Cognition, Lille, France. Guillaume Vaiva has authored or co-authored 12 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2011 and 2025. Their work focuses on Suicide, Bipolar Disorder, COVID, Depression (MDD), and Posttraumatic Stress Disorder.

Publications

JCP
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
Original Research

Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder

June 23, 2025

Bright light therapy is well tolerated in bipolar disorder, starting at 45 minutes/day, with only 6% of patients experiencing a hypomanic switch and 13% experiencing subsyndromic symptoms, which resolved...
, , , et al
JCP
PTSD and Risk of Suicide Reattempt
Original Research

PTSD and Risk of Suicide Reattempt

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric...
, , , et al
JCP
Mixed Features and Suicide Risk in Individuals With Major Depressive Episode
Original Research

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

November 6, 2024

In a large sample of the French population, mixed features were linked to a higher risk of suicide attempts in patients with a major depressive episode.
, , , et al
JCP
Mortality Within 1 Year After Suicide Attempt
Original Research

Mortality Within 1 Year After Suicide Attempt

September 11, 2023

One in 100 people who attempted suicide died by suicide within 1 year; men aged 45 years or older were at greater risk than other demographic groups.
, , , et al
JCP
Risk Factors for Suicide Reattempts
Original Research

Risk Factors for Suicide Reattempts

February 18, 2021

Understanding risk factors for suicidal behavior is crucial for the development of effective prevention plans. Do anxiety disorders or alcohol use disorder play a role? Learn more in this...
, , , et al
JCP
Original Research

Is COVID-19 Associated With Posttraumatic Stress Disorder?

December 8, 2020

Because COVID-19 is associated with a risk of death and lack of effective treatments, patients are at risk of developing PTSD. This cohort study assessed the prevalence of PTSD...
, , , et al
JCP
Commentary

Preventing Suicide During COVID-19

April 14, 2020

Read commentary on the possibilities for treating patients who have suicidal thoughts and behaviors during the COVID-19 pandemic.
, , , et al
JCP
Original Research

Metabolic Syndrome in Treatment-Resistant Depression

October 15, 2019

This study aimed to estimate the prevalence of metabolic syndrome and its components in patients with treatment-resistant depression and determine correlations with sociodemographic, clinical, and treatment-related factors—read the article...
, , , et al
JCP
Letter to the Editor

Dr Berrouiguet and Colleagues Reply

June 18, 2019

Berrouiguet and colleagues reply to the letter "Beyond Statistical Significance: An Underrated Suicide Prevention Intervention" by Martínez-Alés et al.
, ,
JCP
Original Research

Brief Contact Interventions as Suicide Prevention Strategies

September 25, 2018

Once a patient is discharged after a suicide attempt, what can be done to prevent another attempt? This study evaluated a suicide prevention strategy algorithm versus treatment as usual...
, , , et al
PCC
Letter to the Editor

Prediction of Trauma-Related Disorders: A Proposed Cutoff Score for the Peritraumatic Distress Inventory

January 10, 2013

, , , et al
JCP
Original Research

Late-Life Health Consequences of Exposure to Trauma in a General Elderly Population: The Mediating Role of Reexperiencing Posttraumatic Symptoms

July 15, 2011

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe